echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Medicine: The next decade of the pharmaceutical industry, "innovation enterprise is king"

    Medicine: The next decade of the pharmaceutical industry, "innovation enterprise is king"

    • Last Update: 2020-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    the main point of view medicine from traditional industries, but there are innovative genes, innovation is the pharmaceutical industry's eternal theme, but also one of the three main lines we recommended in 2014;Chinese enterprises not only began to break through in the research and development of patented drugs, CMO and CRO enterprises also through integration into the global patent drug industry chain to obtain significant growth;The size of China's domestic market has also provided domestic companies with the opportunity to introduce foreign patented drugs to grow rapidly,
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.